The FlexTouch is Novo Nordisk's Followup to the Venerable FlexPen
Rebecca Byers — June 24, 2015 — Tech
References: novonordisk & healthline
The FlexTouch is the latest prefilled insulin device from Danish global healthcare company Novo Nordisk. The new device, used by individuals with diabetes, provides a new insulin delivery experience and is a followup to the highly successful and popular FlexPen, which dominated the industry for the past decade.
The FlexTouch has a bevy of helpful features that reflect the technological innovations that have emerged in the last ten years. Voted easiest to use by medical professionals and patients, the FlexTouch is designed to be user-friendly and is advertised as requiring five times less pressure to inject than other comparative devices. Additionally, the FlexTouch boasts the inclusion of an end-of-dose "click," which makes confidence in the process easier.
The FlexTouch has a bevy of helpful features that reflect the technological innovations that have emerged in the last ten years. Voted easiest to use by medical professionals and patients, the FlexTouch is designed to be user-friendly and is advertised as requiring five times less pressure to inject than other comparative devices. Additionally, the FlexTouch boasts the inclusion of an end-of-dose "click," which makes confidence in the process easier.
Trend Themes
1. Prefilled Insulin Pens - Disruptive innovation opportunity: Explore further advancements in technology and design to enhance user-friendliness and efficiency in insulin delivery devices.
2. User-friendly Insulin Delivery - Disruptive innovation opportunity: Develop more intuitive and comfortable insulin pens that require less pressure and offer additional features for better user experience.
3. Technological Innovations in Diabetes Care - Disruptive innovation opportunity: Investigate emerging technologies such as smart insulin pens or connected devices that can provide real-time data and personalized insights for diabetes management.
Industry Implications
1. Healthcare - Disruptive innovation opportunity: Integrate digital health technologies with insulin delivery devices to improve patient outcomes and streamline healthcare processes.
2. Medical Device - Disruptive innovation opportunity: Collaborate with pharmaceutical companies to develop next-generation insulin pens with advanced features and better usability.
3. Diabetes Management - Disruptive innovation opportunity: Create holistic solutions that combine insulin delivery devices with data analytics, personalized coaching, and remote monitoring for comprehensive diabetes care.
1.4
Score
Popularity
Activity
Freshness
